Taiwan Pharmaceutical Alliance Engages at 2025 CPHI to Boost International Cooperation and Exports

2025-12-01 / GlobalBio & Investment

Thelargestglobalpharmaceuticalsupplychainevent—the2025ConventiononPharmaceuticalIngredients(CPHI)—concludedonOctober30.Thethemethisyearwas"ShapingFuturePharma."TheMedicalandPharm...

GBIHighlights PRP TIE2025 2025TOA

Spirit Scientific Wins Double Bronze for Regenerative Medicine Innovation at TIE 2025

2025-10-29 / GlobalBio & Investment

CongratulationstoSpiritScientific(7790.TWO)onwinningtwoBronzeMedalsattheTaiwanInnotechExpo2025(TIE2025)! BothawardedpatentsshowcaseadvancementsbuiltontheirBiomaterialLyophilizationTechnology(BMLT):Gro...

GBIHighlights AIinHealthcare MayoClinic

AESOP Technology Joins Mayo Clinic Platform

2025-10-28 / GlobalBio & Investment

BigCongratulationstoAESOPTechnology!AESOPTechnologyJoinsMayoClinicPlatform!AESOPTechnology’sAI-drivendiagnosticsupportsolution,DxPrime,isnowofficiallyaqualifiedsolutionontheMayoClinicPlatform&md...

GBIHighlights BPIPO BioJapan BioJapan2025

Taiwan Biotech Makes a Strong Statement at BioJapan 2025!

2025-10-14 / GlobalBio & Investment

ThemomentumatBioJapan2025surpassedallpreviousyears!FromOctober8–10,theannualbiotecheventheldatPacificoYokohamadrewover9,000participants,markinga137%increasefromlastyear. KeyHighlights:StrongTaiw...

GBIHighlights CellTherapy Exosome

Ever Supreme Bio Acquires Shine Out Biotech for NT$1.7B

2025-10-07 / GlobalBio & Investment

Inaboldstrategicmove,EverSupremeBioTechnologyCo.,Ltd.announcedaNT$1.7billionall-shareacquisitionofShineOutBiotechnologyCo.,Ltd.,aimingtoaccelerateitspositioninexosometherapeuticsandcell-baseddruginnov...

GBIHighlights PostpartumDepression

TWi Biotechnology’s Postpartum Depression Drug Completes U.S. Phase II Enrollment

2025-09-24 / GlobalBio & Investment

TWiBiotechnology’sPostpartumDepressionDrugCompletesU.S.PhaseIIEnrollment TWiBiotechnologyInc.(6610)announcedthatitsoraldrugcandidateNORA520,developedforpostpartumdepression(PPD),hascompletedpati...

GBIHighlights Immunotherapy Antibodies Oncology

AP Biosciences advances next-generation bispecific antibody therapies for solid tumor immunotherapy

2025-09-22 / GlobalBio & Investment

APBiosciences,Inc.isadvancingnext-generationCD137bispecificantibodytherapiesforsolidtumorimmunotherapy. AttheTaiwanImmuno-OncologyDrugDevelopmentForum,founderDr.JengHersharedhowAPBiosciencesisdifferen...

GBIHighlights Apollomics Apollomics Nasdaq

Apollomics Announces Receipt of Nasdaq Delisting Notification, and Will Appeal to Retain Nasdaq List

2025-09-22 / 新聞中心

ApollomicsInc.(Nasdaq:APLM)(“Apollomics”orthe“Company”),aCaliforniabasedlate-stageclinicalbiopharmaceuticalcompanydevelopingmultipleoncologydrugcandidatestoaddressdifficult-to-...

GBIHighlights biobook

In memory of Dr. Chao-pin Hsu—Discover How One Doctor is Transforming Rural Healthcare

2025-09-19 / GlobalBio & Investment

Dr.Chao-pinHsu,DjaikungLuveljeng,knownasthe"SuperDoctor,"haspassedawayon18thSep,2025.Hededicatedhislifetoservingruralcommunities,yetleavesbehindtheunfinisheddreamofcompletingtheSouth-LinkMed...

GBIHighlights Oncology mRNA Immunotherapy

Elixiron Targets T-Cell Exhaustion with Next-Gen Cancer Immunotherapies

2025-09-18 / GlobalBio & Investment

On16thSeptember,Dr.Hung-KaiChen,Founder&CEOofElixironImmunotherapeutics,sharedthecompany’sinnovativepipelineaddressingoneofthetoughestchallengesinoncology—TcellexhaustionattheTaiwanImm...

GBIHighlights NVIDIATAIPEI-1 AIdrugs ADC CAR-T

Topmunnity Secures 2nd Place in NVIDIA TAIPEI-1 Review

2025-09-18 / GlobalBio & Investment

TopmunnityEarns2ndPlaceinNVIDIATAIPEI-1Review,StandingOutastheOnlyTeaminAIDrugDevelopment.On15thSeptember,CEOofTopmunnity AmyHuang(Chao-YuanHuang)announcedthatTopmunnity'sproposal,"One-StopGe...

GBIHighlights ICI Immunotherapy Oncology

GNT Biotech Advances GNTbm-38 with IND Filings in US & China by 2026

2025-09-18 / GlobalBio & Investment

GNTBiotech&MedicalsCorporation(GNTbm)isadvancingGNTbm-38,anext-generationoralimmuno-regulatorydrug,withINDfilingsplannedintheUS&Chinabyearly2026.InvestmentHighlightsGlobalIPStrength:38inventio...